Connor, Clark & Lunn Investment Management (CC&L)’s Castle Biosciences CSTL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.26M	Sell	377,082 -11,409	-3%	-$374K	0.02%	491
2025 Q4	$15.1M	Buy	388,491 +52,600	+16%	+$1.7M	0.04%	352
2025 Q3	$7.65M	Buy	335,891 +209,460	+166%	+$4.25M	0.02%	473
2025 Q2	$2.58M	Sell	126,431 -50,458	-29%	-$934K	0.01%	782
2025 Q1	$3.54M	Buy	176,889 +8,176	+5%	+$202K	0.02%	588
2024 Q4	$4.5M	Buy	168,713 +3,255	+2%	+$99.1K	0.02%	508
2024 Q3	$4.72M	Buy	165,458 +98,571	+147%	+$2.51M	0.02%	447
2024 Q2	$1.46M	Sell	66,887 -10,770	-14%	-$240K	0.01%	753
2024 Q1	$1.72M	Sell	77,657 -10,913	-12%	-$237K	0.01%	720
2023 Q4	$1.91M	Buy	88,570 +7,985	+10%	+$141K	0.01%	678
2023 Q3	$1.36M	Buy	80,585 +19,040	+31%	+$333K	0.01%	726
2023 Q2	$844K	Buy	61,545 +19,363	+46%	+$392K	﹤0.01%	847
2023 Q1	$958K	Buy	42,182 +14,038	+50%	+$343K	0.01%	724
2022 Q4	$663K	Buy	28,144 +5,053	+22%	+$117K	﹤0.01%	806
2022 Q3	$602K	Buy	23,091 +3,628	+19%	+$102K	﹤0.01%	778
2022 Q2	$427K	Buy	+19,463	New	+$452K	﹤0.01%	816